These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 366561)

  • 1. [The heterogeneity of micropolycystic ovary syndrome. 77 cases (author's transl)].
    Bremond A; Blanc MC; Rochet Y
    Nouv Presse Med; 1978 Nov; 7(41):3733-6. PubMed ID: 366561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Stein-Leventhal syndrome. Clinical, biological and anatomic study of 6 cases in adolescent girls (author's transl)].
    Petrus M; Claverie J; Vancina S; Becue J; Dutau G; Rochiccioli P
    Arch Fr Pediatr; 1981; 38(6):417-22. PubMed ID: 6794535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinaemia in polycystic ovary syndrome.
    Lunde O
    Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of polycystic ovary syndrome and preliminary studies on its mechanism.
    Lin SQ; Ge QS; Gu CX; Feng DD; Wang HL
    Chin Med J (Engl); 1985 Feb; 98(2):95-102. PubMed ID: 3922696
    [No Abstract]   [Full Text] [Related]  

  • 7. Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.
    Polansky S
    Obstet Gynecol; 1975 Apr; 45(4):451-4. PubMed ID: 1121374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary polycystic ovary syndrome in a premenarchal girl. A case report.
    Rao JK; Chihal HJ; Johnson CM
    J Reprod Med; 1985 Apr; 30(4):361-5. PubMed ID: 3925138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
    Rossmanith WG; Keckstein J; Spatzier K; Lauritzen C
    Gynakol Rundsch; 1991; 31 Suppl 2():333-5. PubMed ID: 1790971
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inappropriate gonadotropin secretion in the polycystic ovary syndrome].
    Pilotti L; Data PG; Di Tano G
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1885-90. PubMed ID: 6440582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1989; 20(1):35-7. PubMed ID: 2528880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ovarian wedge resection for polycystic ovary syndrome: analysis of 28 cases].
    Zhu RL
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):290-3, 319. PubMed ID: 3936686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thyrotropic reserve in Sheehan's syndrome. Study in 36 patients (author's transl)].
    Boucekkine C; Maoui R; Klioua R; Chitour F; Benmiloud M
    Nouv Presse Med; 1980 Feb; 9(7):427-31. PubMed ID: 6244530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
    Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
    Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovarian disease in a teenager.
    J Tenn Med Assoc; 1971 Nov; 64(11):959-63. PubMed ID: 5121183
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pituitary double-stimulation with synthetic LH-releasing-hormone on three consecutive days in men, menstruating and amenorrhoic women (author's transl)].
    Römmler A; Baumgarten S; Hammerstein J
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):842-50. PubMed ID: 4613597
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
    Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
    Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.